References
- Adams RD, Victor M, Mancall EL: Central pontine myelinolysis: a
hitherto undescribed disease occurring in alcoholic and malnourished
patients. MA Arch Neurol Psychiatr. 1959; 81:154-72.
- Singh TD, Fugate JE, Rabinstein AA: Central pontine and extrapontine
myelinolysis: a systematic review. Eur J Neurol . 2014;
21:1443-50.
- Simpson DM, Hallett M, Ashman EJ, et al: Practice guideline update
summary: Botulinum neurotoxin for the treatment of blepharospasm,
cervical dystonia, adult spasticity, and headache. Report of the
Guideline Development Subcommittee of the American Academy of
Neurology. Neurology 2016, 86, 1818–1826.
- Rosales RL, Chua-Yap, AS: Evidence-based systematic review on the
efficacy and safety of botulinum toxin-A therapy in post-stroke
spasticity. J. Neural Transm. 2008, 115, 617–623.
- Andringa A, van de Port I, van Wegen E, et al: Effectiveness of
botulinum toxin treatment for upper limb spasticity after stroke over
different ICF domains: A systematic review and meta-analysis.Arch. Phys. Med. Rehabil. 2019, 100, 1703–1725.
- Francisco GE, Li S. Spasticity. In Braddom’s Physical Medicine
and Rehabilitation , 5th ed.; Elsevier: Philadelphia, PA, USA, 2015.
- Sethi N, Singh S, DeBoulle K, et al: A Review of Complications Due to
the Use of Botulinum Toxin A for Cosmetic Indications. Aesth
Plast Surg 2020; Published online,
https://doi.org/10.1007/s00266-020-01983-w
- Ramirez-Castaneda J, Jankovic J: Long-term efficacy and safety of
botulinum toxin injections in dystonia. Toxins(Basel)2013;5(2):249–66.
- Baizabal-Carvallo JF, Jankovic J, Pappert E: Flu-like symptoms
following botulinum toxin therapy. Toxicon 2011;58(1):1–7.
- Moore AP: Movement, visceral and autonomic disorders: use of botulinum
toxin. Hospital Med 2003;64:452–9.
- Oliver, JD, Boesch RP, Mack KJ: Decreased Pulmonary Function During
Botulinum Toxin A Therapy for Chronic Migraines in a 17‐Year‐Old
Female. Headache: The Journal of Head and Face Pain2018;58 (8), 1259-1261.
- Schoene R, Brashear A, Turkel CC, et al: A Randomized, Double-Blind,
Placebo-Controlled, Parallel Group Multicenter Study Evaluating the
Effect of Botulinum Toxin Type A Treatment on Pulmonary Function in
Patients With Poststroke Focal Spasticity. Archives of Physical
Medicine and Rehabilitation 2006; 87(11), e10.
- Taysse L, Daulon S, Calvet JH, et al: Induction of acute lung injury
after intranasal administration of toxin botulinum a complex.Toxicologic pathology 2005;33 (3), 336-342.
- Ermert LE, Bruckner HE, Walmrath DI, et al: Role of endothelial
cytoskeleton in high-permeability edema due to botulinum C2 toxin in
perfused rabbit lungs. American Journal of Physiology-Lung
Cellular and Molecular Physiology 1995, 268.5: L753-L761.
- Ermert L, Duncker HR, Bruckner H, et al: Ultrastructural changes of
lung capillary endothelium in response to botulinum C2 toxin.Journal of Applied Physiology 1997, 82.2: 382-388.